Challenges and complications of poly (lactic-co-glycolic acid)-based long-acting drug product development
Poly(lactic-co-glycolic acid) (PLGA) is one of the preferred polymeric inactive ingredients for long-acting parenteral drug products that are constituted of complex formulations. Despite over 30 years of use, there are still many challenges faced by researchers in formulation-related aspects pertain...
Main Authors: | Lim, Yi Wen, Tan, Wen Siang, Ho, Kok Lian, Mariatulqabtiah, Abdul Razak, Abu Kasim, Noor Hayaty, Abd. Rahman, Noorsaadah, Wong, Tin Wui, Chee, Chin Fei Chee |
---|---|
Format: | Article |
Published: |
MDPI
2022
|
Similar Items
-
Challenges and Complications of Poly(lactic-<i>co</i>-glycolic acid)-Based Long-Acting Drug Product Development
by: Yi Wen Lim, et al.
Published: (2022-03-01) -
Polyethylene glycol-coated porous magnetic nanoparticles for targeted delivery of chemotherapeutics under magnetic hyperthermia condition
by: Ali Dabbagh, et al.
Published: (2019-01-01) -
Shielding of hepatitis B virus-like nanoparticle with poly(2-ethyl-2-oxazoline)
by: Fam, See Yee, et al.
Published: (2019) -
Experimental comparative study of the histotoxicity of poly(lactic-co-glycolic acid) copolymer and poly(lactic-co-glycolic acid)-poly(isoprene) blend
by: Jung Ho Kim, et al.
Published: (2014-10-01) -
The development and challenges of poly (lactic acid) and poly (glycolic acid)
by: K. Jim Jem, et al.
Published: (2020-04-01)